Asthma and Respiratory Disorders News

Mepolizumab use was associated with fewer exacerbations, reduced oral corticosteroid use and lower costs among patients with asthma on Medicaid, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Sensitization to Staphylococcal enterotoxin was correlated with type 2-high inflammation among children with moderate to severe asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Hay fever was less common among children who lived on a farm and consumed unprocessed cow’s milk than among other children in rural areas, according to a study in The Journal of Allergy, Asthma and Clinical Immunology: In Practice.

Exposure to mouse allergen was associated with air trapping but not with airflow limitation in a low-income, urban pediatric asthma population, according to a study published in The Journal of Allergy and Clinical Immunology.

Respiratory viruses contributed to the excess burden of asthma-related visits to the ED for children in racial and ethnic minority groups outside of the COVID-19 lockdown, according to study results.

Researchers found no association between prenatal exposure to acid-suppressive medications and risk for allergic diseases in children, according to a study published in JAMA Pediatrics.

Women with mild asthma have worse small airway function, lower fractional exhaled nitric oxide and more prominent declines in these parameters with age than men, according to a study published in Annals of Allergy, Asthma & Immunology.

Long-term treatment with dupilumab appeared effective among patients with asthma with or without coexisting chronic rhinosinusitis with nasal polyps, according to a study published in Annals of Allergy, Asthma & Immunology.

The FDA approved a pressurized metered-dose inhaler with a fixed-dose combination of albuterol and budesonide for use as rescue medication among patients with asthma aged 18 years and older, according to a manufacturer-issued press release.

Dupilumab facilitated the reversal of persistent airflow obstruction and improved clinical outcomes among patients with uncontrolled moderate to severe asthma, according to a post-hoc analysis in Annals of Allergy, Asthma & Immunology.